Updated guidelines on screening for gestational diabetes

Yashdeep Gupta,1 Bharti Kalra,2 Manash P Baruah,3 Rajiv Singla,4 Sanjay Kalra2 1Department of Medicine, Government Medical College and Hospital, Chandigarh, India; 2Bharti Hospital, Karnal, Haryana, India; 3Excel Center, Guwahati, Assam, India; 4Saket City Hospital, New Delhi, India Abstract: Gest...

Full description

Bibliographic Details
Main Authors: Gupta Y, Kalra B, Baruah MP, Singla R, Kalra S
Format: Article
Language:English
Published: Dove Medical Press 2015-05-01
Series:International Journal of Women's Health
Online Access:http://www.dovepress.com/updated-guidelines-on-screening-for-gestational-diabetes-peer-reviewed-article-IJWH
_version_ 1811298422582411264
author Gupta Y
Kalra B
Baruah MP
Singla R
Kalra S
author_facet Gupta Y
Kalra B
Baruah MP
Singla R
Kalra S
author_sort Gupta Y
collection DOAJ
description Yashdeep Gupta,1 Bharti Kalra,2 Manash P Baruah,3 Rajiv Singla,4 Sanjay Kalra2 1Department of Medicine, Government Medical College and Hospital, Chandigarh, India; 2Bharti Hospital, Karnal, Haryana, India; 3Excel Center, Guwahati, Assam, India; 4Saket City Hospital, New Delhi, India Abstract: Gestational diabetes mellitus (GDM) is associated with an increased risk of complications for both mother and baby during pregnancy as well as in the postpartum period. Screening and identifying these high-risk women is important to improve short- and long-term maternal and fetal outcomes. However, there is a lack of international uniformity in the approach to the screening and diagnosis of GDM. The main purpose of this review is to provide an update on screening for GDM and overt diabetes during pregnancy, and discuss the controversies in this field. We take on debatable issues such as adoption of the new International association of diabetes and pregnancy study groups criteria instead of the Carpenter and Coustan criteria, one-step versus two-step screening, universal screening versus high-risk screening before 24 weeks of gestation for overt diabetes, and, finally, the role of HbA1c as a screening test of GDM. This discussion is followed by a review of recommendations by professional bodies. Certain clinical situations, in which a pragmatic approach is needed, are highlighted to provide a comprehensive overview of the subject. Keywords: pregnancy, guidelines, IADPSG, GDM, Carpenter and Coustan criteria
first_indexed 2024-04-13T06:19:02Z
format Article
id doaj.art-6a94d2268db54d3ca298eb065a3319fc
institution Directory Open Access Journal
issn 1179-1411
language English
last_indexed 2024-04-13T06:19:02Z
publishDate 2015-05-01
publisher Dove Medical Press
record_format Article
series International Journal of Women's Health
spelling doaj.art-6a94d2268db54d3ca298eb065a3319fc2022-12-22T02:58:42ZengDove Medical PressInternational Journal of Women's Health1179-14112015-05-012015default53955021799Updated guidelines on screening for gestational diabetesGupta YKalra BBaruah MPSingla RKalra SYashdeep Gupta,1 Bharti Kalra,2 Manash P Baruah,3 Rajiv Singla,4 Sanjay Kalra2 1Department of Medicine, Government Medical College and Hospital, Chandigarh, India; 2Bharti Hospital, Karnal, Haryana, India; 3Excel Center, Guwahati, Assam, India; 4Saket City Hospital, New Delhi, India Abstract: Gestational diabetes mellitus (GDM) is associated with an increased risk of complications for both mother and baby during pregnancy as well as in the postpartum period. Screening and identifying these high-risk women is important to improve short- and long-term maternal and fetal outcomes. However, there is a lack of international uniformity in the approach to the screening and diagnosis of GDM. The main purpose of this review is to provide an update on screening for GDM and overt diabetes during pregnancy, and discuss the controversies in this field. We take on debatable issues such as adoption of the new International association of diabetes and pregnancy study groups criteria instead of the Carpenter and Coustan criteria, one-step versus two-step screening, universal screening versus high-risk screening before 24 weeks of gestation for overt diabetes, and, finally, the role of HbA1c as a screening test of GDM. This discussion is followed by a review of recommendations by professional bodies. Certain clinical situations, in which a pragmatic approach is needed, are highlighted to provide a comprehensive overview of the subject. Keywords: pregnancy, guidelines, IADPSG, GDM, Carpenter and Coustan criteriahttp://www.dovepress.com/updated-guidelines-on-screening-for-gestational-diabetes-peer-reviewed-article-IJWH
spellingShingle Gupta Y
Kalra B
Baruah MP
Singla R
Kalra S
Updated guidelines on screening for gestational diabetes
International Journal of Women's Health
title Updated guidelines on screening for gestational diabetes
title_full Updated guidelines on screening for gestational diabetes
title_fullStr Updated guidelines on screening for gestational diabetes
title_full_unstemmed Updated guidelines on screening for gestational diabetes
title_short Updated guidelines on screening for gestational diabetes
title_sort updated guidelines on screening for gestational diabetes
url http://www.dovepress.com/updated-guidelines-on-screening-for-gestational-diabetes-peer-reviewed-article-IJWH
work_keys_str_mv AT guptay updatedguidelinesonscreeningforgestationaldiabetes
AT kalrab updatedguidelinesonscreeningforgestationaldiabetes
AT baruahmp updatedguidelinesonscreeningforgestationaldiabetes
AT singlar updatedguidelinesonscreeningforgestationaldiabetes
AT kalras updatedguidelinesonscreeningforgestationaldiabetes